Skip to Content
Merck
  • Augmentation with sulpiride for a schizophrenic patient partially responsive to clozapine.

Augmentation with sulpiride for a schizophrenic patient partially responsive to clozapine.

Acta psychiatrica Scandinavica (2000-12-01)
J H Stubbs, C M Haw, C J Staley, C Q Mountjoy
ABSTRACT

Schizophrenic patients who are only partially responsive to clozapine pose a therapeutic challenge. In these circumstances some clinicians would consider adding in a second antipsychotic. We present a case report and review evidence for the efficacy of such augmentation strategies. Single case report and literature review. The total number of patients in studies and case reports of combining clozapine with other antipsychotics is small. There has been only one randomized controlled trial. This found the addition of sulpiride to clozapine resulted in clinical improvement in some patients. Further randomized controlled studies of augmentation of clozapine therapy are needed to provide scientific justification for this clinical practice.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
(±)-Sulpiride
Sulpiride, European Pharmacopoeia (EP) Reference Standard